House Bill #5679 (2023)

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT

Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name on list.

View full text
View status on official RI website

Subscribe to email updates

• 2023-02-17: Introduced, referred to House Health & Human Services
• 2023-03-10: Scheduled for hearing and/or consideration (03/15/2023) [Show]
• 2023-03-15: Committee recommended measure be held for further study

---

Votes

RIBIT does not have any votes for this legislation yet.
(Vote tracking on RIBIT is still a work-in-progress, so make sure to check the official RI website, too!)